Latest debt-to-equity ratio
20/20 Biolabs Debt-to-equity ratio
Direct answer
20/20 Biolabs's debt-to-equity ratio is 18.12%.
The verified market snapshot reports 18.12%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked November 12, 2026.
Get free 20/20 Biolabs email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 18.12%
Explore related company data
View 20/20 Biolabs's market capitalizationView 20/20 Biolabs's price-to-book ratioView 20/20 Biolabs's return on equityView 20/20 Biolabs's dividend yieldView 20/20 Biolabs's 52-week price rangeView 20/20 Biolabs's revenue growthView 20/20 Biolabs's profit marginView all 20/20 Biolabs key metricsReturn to 20/20 Biolabs profile